$FONR
FONAR CORP Stock $fonr

$fonr Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-K Financial Statement

#000035501915000031 Filed on September 29, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2015
Revenue	$16.88M	$502.0K	$2.005M
YoY Change	-0.86%	1.41%	2.1%
Cost Of Revenue	$9.700M	$352.0K	$1.882M
YoY Change	3.74%	57.85%	76.38%
Gross Profit	$7.180M	$150.0K	$122.8K
YoY Change	-6.51%	-44.85%	-86.31%
Gross Profit Margin	42.54%	29.88%	6.12%
Selling, General & Admin	$3.290M	$3.706M	$17.45M
YoY Change	-25.4%	-5.82%	-6.11%
% of Gross Profit	45.82%	2470.67%	14212.19%
Research & Development	$700.0K	$360.0K	$1.812M
YoY Change	11.11%	0.0%	2.93%
% of Gross Profit	9.75%	240.0%	1476.25%
Depreciation & Amortization	$870.0K	$889.0K	$3.544M
YoY Change	-6.45%	-4.72%	-7.14%
% of Gross Profit	12.12%	592.67%	2887.08%
Operating Expenses	$3.980M	$4.066M	$19.26M
YoY Change	-21.03%	-5.33%	-5.33%
Operating Profit	$3.200M	-$3.916M	-$19.14M
YoY Change	21.21%	-2.66%	-1.6%
Interest Expense	-$100.0K	-$169.0K	-$702.1K
YoY Change	-28.57%	-183.25%	-20.63%
% of Operating Profit	-3.13%
Other Income/Expense, Net	$400.0K		$13.00
YoY Change	-180.0%		-100.27%
Pretax Income	$3.490M	$2.549M	$12.82M
YoY Change	74.5%	15.24%	16.01%
Income Tax	-$2.710M	$30.00K	$2.613M
% Of Pretax Income	-77.65%	1.18%	20.38%
Net Earnings	$6.200M	$2.019M	$12.91M
YoY Change	35.31%	16.1%	24.19%
Net Earnings / Revenue	36.73%	402.19%	643.92%
Basic Earnings Per Share	$0.89	$0.33	$2.13
Diluted Earnings Per Share	$0.86	$0.31	$1.955M
COMMON SHARES
Basic Shares Outstanding		6.050M shares	6.051M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.400M	$7.800M	$9.400M
YoY Change	-6.0%	-18.75%	-6.0%
Cash & Equivalents	$9.449M	$7.828M	$9.400M
Short-Term Investments
Other Short-Term Assets	$900.0K	$900.0K	$900.0K
YoY Change	-10.0%	-47.06%	-10.0%
Inventory	$2.900M	$3.000M	$2.900M
Prepaid Expenses
Receivables	$30.40M	$4.500M	$30.40M
Other Receivables	$0.00	$26.90M	$0.00
Total Short-Term Assets	$43.62M	$43.08M	$43.60M
YoY Change	1.87%	-0.62%	1.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.90M	$13.45M	$12.90M
YoY Change	-14.16%	-16.15%	-14.0%
Goodwill	$1.767M	$1.767M
YoY Change	0.0%	0.0%
Intangibles	$8.950M	$9.653M
YoY Change	-14.83%	-12.59%
Long-Term Investments
YoY Change
Other Assets	$9.300M	$6.600M	$9.300M
YoY Change	38.81%	69.23%	38.81%
Total Long-Term Assets	$32.88M	$31.43M	$32.90M
YoY Change	-3.23%	-4.07%	-3.24%
TOTAL ASSETS
Total Short-Term Assets	$43.62M	$43.08M	$43.60M
Total Long-Term Assets	$32.88M	$31.43M	$32.90M
Total Assets	$76.50M	$74.50M	$76.50M
YoY Change	-0.39%	-2.1%	-0.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.782M	$2.304M	$1.800M
YoY Change	-28.19%	-19.52%	-28.0%
Accrued Expenses	$7.300M	$8.000M	$7.300M
YoY Change	-1.35%	-10.11%	-7.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.500M	$2.900M	$2.500M
YoY Change	-13.79%	-3.33%	-13.79%
Total Short-Term Liabilities	$18.79M	$20.26M	$18.80M
YoY Change	-10.18%	-8.67%	-10.05%
LONG-TERM LIABILITIES
Long-Term Debt	$5.700M	$6.300M	$5.700M
YoY Change	-32.94%	-32.98%	-32.94%
Other Long-Term Liabilities	$700.0K	$400.0K	$700.0K
YoY Change	-22.22%	-42.86%	-22.22%
Total Long-Term Liabilities	$6.916M	$7.283M	$6.400M
YoY Change	-30.56%	-30.84%	-31.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.79M	$20.26M	$18.80M
Total Long-Term Liabilities	$6.916M	$7.283M	$6.400M
Total Liabilities	$25.71M	$27.55M	$38.10M
YoY Change	-16.76%	-15.8%	-26.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$136.3M
YoY Change	-8.65%
Common Stock	$175.4M	$175.4M
YoY Change	0.09%	0.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)	-$675.0K	$675.0K
YoY Change	-200.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$50.78M	$32.70M	$38.40M
YoY Change
Total Liabilities & Shareholders Equity	$76.49M	$74.54M	$76.50M
YoY Change	-0.39%	-2.11%	-0.39%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2015
OPERATING ACTIVITIES
Net Income	$6.200M	$2.019M	$12.91M
YoY Change	35.31%	16.1%	24.19%
Depreciation, Depletion And Amortization	$870.0K	$889.0K	$3.544M
YoY Change	-6.45%	-4.72%	-7.14%
Cash From Operating Activities	$4.720M	$2.640M	$13.27M
YoY Change	17.71%	2.33%	-0.88%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	-$110.0K	-$131.3K
YoY Change	-85.71%	-47.62%	-78.85%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change
Cash From Investing Activities	-$40.00K	-$110.0K	-$270.8K
YoY Change	-85.71%	-47.62%	-67.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.070M	-6.370M	-$13.51M
YoY Change	-8.63%	189.55%	28.93%
NET CHANGE
Cash From Operating Activities	4.720M	2.640M	$13.27M
Cash From Investing Activities	-40.00K	-110.0K	-$270.8K
Cash From Financing Activities	-3.070M	-6.370M	-$13.51M
Net Change In Cash	1.610M	-3.840M	-$502.9K
YoY Change	335.14%	-2358.82%	-124.17%
FREE CASH FLOW
Cash From Operating Activities	$4.720M	$2.640M	$13.27M
Capital Expenditures	-$40.00K	-$110.0K	-$131.3K
Free Cash Flow	$4.760M	$2.750M	$13.40M
YoY Change	10.96%	-1.43%	-4.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	dei	Entity Public Float EntityPublicFloat	63000000	usd
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6050840	shares
CY2015Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9448798	usd
CY2014Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9951736	usd
CY2015Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	681660	usd
CY2014Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	759809	usd
CY2015Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2191849	usd
CY2014Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2443536	usd
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860040	usd
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1011358	usd
CY2015Q2	us-gaap	Assets Current AssetsCurrent	43620813	usd
CY2014Q2	us-gaap	Assets Current AssetsCurrent	42821790	usd
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12901195	usd
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15029729	usd
CY2015Q2	us-gaap	Other Assets OtherAssets	829505	usd
CY2014Q2	us-gaap	Other Assets OtherAssets	922096	usd
CY2015Q2	us-gaap	Assets Net AssetsNet	76492077	usd
CY2014Q2	us-gaap	Assets Net AssetsNet	76789843	usd
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1782442	usd
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2481997	usd
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8252633	usd
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	175447586	usd
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	175284437	usd
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136348635	usd
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149259286	usd
CY2015Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8750286	usd
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4187401	usd
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4730962	usd
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18792652	usd
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20923091	usd
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6915912	usd
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9960160	usd
CY2015Q2	us-gaap	Liabilities Liabilities	25708564	usd
CY2014Q2	us-gaap	Liabilities Liabilities	30883251	usd
CY2014Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2015Q2	us-gaap	Minority Interest MinorityInterest	12390771	usd
CY2014Q2	us-gaap	Minority Interest MinorityInterest	20594984	usd
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	50783513	usd
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	45906592	usd
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	37799276	usd
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	11101065	usd
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76492077	usd
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76789843	usd
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	69050996	usd
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	68505477	usd
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	17096000	usd
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	17040000	usd
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	49141814	usd
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	17985000	usd
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	16831000	usd
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	17092000	usd
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	17609000	usd
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	16878000	usd
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	17025000	usd
CY2015	us-gaap	Net Income Loss NetIncomeLoss	12910651	usd
CY2014	us-gaap	Net Income Loss NetIncomeLoss	10396130	usd
CY2013	us-gaap	Net Income Loss NetIncomeLoss	8678542	usd
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6050632	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6009822	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5933318	shares
CY2015	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	413589	usd
CY2014	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	250523	usd
CY2013	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	66619	usd
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4258147	usd
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4044002	usd
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3717440	usd
CY2015	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	78149	usd
CY2014	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-314067	usd
CY2013	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	682854	usd
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	251687	usd
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-366448	usd
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	117861	usd
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	67192	usd
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	46967	usd
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-698284	usd
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	41125	usd
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	131811	usd
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-204037	usd
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-131308	usd
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-620697	usd
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-1135382	usd
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-139534	usd
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-214211	usd
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-159907	usd
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-270842	usd
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-834908	usd
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41295289	usd
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-2788401	usd
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-4400128	usd
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-1821617	usd
CY2015	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	7333	usd
CY2014	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15992	usd
CY2013	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15993	usd
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4627851	usd
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4965770	usd
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-1799950	usd
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13505013	usd
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10475006	usd
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29594857	usd
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-502938	usd
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2081009	usd
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4161288	usd
CY2015	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53200	usd
CY2014	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	223000	usd
CY2013	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	415021	usd
CY2015	FONR	Capital Stock And Options Disclosure Textblock CapitalStockAndOptionsDisclosureTextblock	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - CAPITAL STOCK</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class B Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146, 146 and 146 of such shares outstanding at June 30, 2015, 2014 and 2013, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class C Common Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Class A Non-Voting Preferred Stock</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Stock Bonus Plans</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2015, 953,367 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2015, 2014 and 2013, 5,000, 46,708 and 67,870 shares were issued, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Options</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONARs 2002 Incentive Stock Option Plan (the FONAR 2002 Plan), adopted on July 1, 2002, is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2002 Plan permits the issuance of stock options covering an aggregate of 100,000 shares of common stock of FONAR. The options have an exercise price equal to the fair market value of the underlying stock on the date the option is granted, are nontransferable, are exercisable for a period not exceeding ten years and expire upon the voluntary termination of employment. The FONAR 2002 Plan terminated on June 30, 2012. During the year ended June 30, 2014, 6,610 options expired, therefore no options remain outstanding.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONARs 2005 Incentive Stock Option Plan (the FONAR 2005 Plan), adopted on February 16, 2005,is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2005 Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock of FONAR. The options have an exercise price equal to the fair value of the underlying stock on the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination of employment. The FONAR 2005 Plan terminated on February 14, 2015 and no options remain outstanding.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stock option activity and weighted average exercise prices under these plans and grants for the year ended June 30, 2015, 2014 and 2013 was as follows:</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Number of Options</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; padding-left: 5.4pt">Outstanding, June 30, 2012</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">14,022</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">27.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,412</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26.65</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Outstanding, June 30, 2013</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,610</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">29.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2014</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2015</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Exercisable at:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">June 30, 2013</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,610</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">29.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">June 30, 2014</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">June 30, 2015</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</p>
CY2015	us-gaap	Revenue Recognition Percentage Of Completion Method RevenueRecognitionPercentageOfCompletionMethod	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included in product sales in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, Revenue Recognition Construction-Type and Production-Type Contracts. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from sales of other items is recognized upon shipment.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2015, the Company has twenty management agreements of which three are with PCs owned by Raymond V. Damadian, M.D., President and Chairman of the Board of FONAR (the Related medical practices) and seventeen are with PCs, which are all located in the state of New York (the New York PCs), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $100,000 to $242,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PCs. The lease fee for the medical equipment consists of a fixed monthly fee of $2,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient fee revenue, net of contractual allowance and discounts, consist of net patient fees received from insurance companies, third party payors (including federal and state agencies under Medicare and Medicaid programs), hospitals and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. Patient fee revenue is recorded in the period in which services are provided.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Companys patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2015, 2014 and 2013 are summarized in the following table.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,398,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,360,536</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,187,690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">541,602</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,978,243</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,597,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,589,076</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,277,128</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,982,311</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,153,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481,865</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,770,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,333,082</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,584,669</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,383,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,897,196</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>
CY2015	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Customer Advances</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p>
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Concentration of Credit Risk</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2015, the Company had cash on deposit of approximately $7,038,000 in excess of federally insured limits of $250,000.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties accounted for approximately 11%, 11% and 16% of the consolidated net revenues for the years ended June 30, 2015, 2014 and 2013, respectively. Net management fee receivables from the related party medical practices accounted for approximately 12%, 12% and 9% of the consolidated accounts receivable for the years ended June 30, 2015, 2014 and 2013, respectively.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 3 regarding the Companys concentrations in the healthcare industry.</p>
CY2015	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Reclassifications</u></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.</p>
CY2014Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2069055	usd
CY2015Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2550627	usd
CY2014Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2550627	usd
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18758344	usd
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17650043	usd
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7004847	usd
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7418436	usd
CY2015Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4547545	usd
CY2014Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4408011	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10502232	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9217604	usd
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.13
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.46
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.64
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2015Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2043411	usd
CY2014Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2093671	usd
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	148438	usd
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	349865	usd
CY2015Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	620307	usd
CY2014Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	620307	usd
CY2015Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	17396797	usd
CY2014Q2	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	17396797	usd
CY2015Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3580224	usd
CY2014Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3510224	usd
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2069055	usd
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2015Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4502915	usd
CY2014Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5593148	usd
CY2015Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	939614	usd
CY2014Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	939614	usd
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31659539	usd
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32679772	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8950160	usd
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10508843	usd
CY2015Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	10508843	usd
CY2014Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	11904248	usd
CY2013Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	3835179	usd
CY2015Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	139534	usd
CY2014Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	214211	usd
CY2013Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	9359907	usd
CY2015Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-413589	usd
CY2014Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-250523	usd
CY2013Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-66619	usd
CY2015Q2	FONR	Balance End Of Year Balance_EndOfYear	8950160	usd
CY2014Q2	FONR	Balance End Of Year Balance_EndOfYear	10508843	usd
CY2013Q2	FONR	Balance End Of Year Balance_EndOfYear	11904248	usd
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6610	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14022	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.76
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	26.65
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2014Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6961016	usd
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2015	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	114683	usd
CY2014	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	310000	usd
CY2013	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	125000	usd
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	29313	usd
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	24093	usd
CY2013	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	71001	usd
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6607107	usd
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	115346	usd
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	65108	usd
CY2015Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	6751692	usd
CY2014Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	5644097	usd
CY2015Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	111190	usd
CY2014Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	195408	usd
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	63849156	usd
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67896587	usd
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-55425850	usd
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-62156300	usd
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8423306	usd
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5740287	usd
CY2015Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-510492	usd
CY2014Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-583990	usd
CY2015Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-510492	usd
CY2014Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-583990	usd
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7912814	usd
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5156297	usd
CY2015Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	991603	usd
CY2014Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	834324	usd
CY2015Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	117480	usd
CY2014Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	117480	usd
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	521149	usd
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	664349	usd
CY2015Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2538340	usd
CY2014Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2665181	usd
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	344060	usd
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	438730	usd
CY2015Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	235000	usd
CY2014Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	325139	usd
CY2015Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	486011	usd
CY2014Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	582740	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3717939	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3191082	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2722882	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2129428	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8094188	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	21721796	usd
CY2015	us-gaap	Revenues Revenues	2005000	usd
CY2014	us-gaap	Revenues Revenues	1963750	usd
CY2013	us-gaap	Revenues Revenues	1200000	usd
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12899877	usd
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12302669	usd
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7535747	usd
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3544470	usd
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3817205	usd
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2421177	usd
CY2015	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	53200	usd
CY2014	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	223000	usd
CY2013	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	415021	usd
CY2015	FONR	Identifiable Assets IdentifiableAssets	76492077	usd
CY2014	FONR	Identifiable Assets IdentifiableAssets	76789843	usd
CY2013	FONR	Identifiable Assets IdentifiableAssets	73150650	usd
CY2015	FONR	Capital Expenditures CapitalExpenditures	270842	usd
CY2014	FONR	Capital Expenditures CapitalExpenditures	834908	usd
CY2013	FONR	Capital Expenditures CapitalExpenditures	25407939	usd
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1820979	usd
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1877932	usd
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3939140	usd
CY2015	us-gaap	Maintenance Revenue MaintenanceRevenue	9549316	usd
CY2014	us-gaap	Maintenance Revenue MaintenanceRevenue	10082631	usd
CY2013	us-gaap	Maintenance Revenue MaintenanceRevenue	10841935	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	28153598	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	24307192	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	7481865	usd
CY2015	us-gaap	Management Fees Revenue ManagementFeesRevenue	34805627	usd
CY2014	us-gaap	Management Fees Revenue ManagementFeesRevenue	34839969	usd
CY2013	us-gaap	Management Fees Revenue ManagementFeesRevenue	21493599	usd
CY2015	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7381725	usd
CY2014	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7620835	usd
CY2013	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7859944	usd
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1882230	usd
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1067120	usd
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3656635	usd
CY2015	us-gaap	Maintenance Costs MaintenanceCosts	2189373	usd
CY2014	us-gaap	Maintenance Costs MaintenanceCosts	2496985	usd
CY2013	us-gaap	Maintenance Costs MaintenanceCosts	3213420	usd
CY2015	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	25220	usd
CY2014	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	27242	usd
CY2013	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	32603	usd
CY2015	us-gaap	Service Management Costs ServiceManagementCosts	20970116	usd
CY2014	us-gaap	Service Management Costs ServiceManagementCosts	20851065	usd
CY2013	us-gaap	Service Management Costs ServiceManagementCosts	12998243	usd
CY2015	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	5397818	usd
CY2014	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	5134553	usd
CY2013	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3515706	usd
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1812398	usd
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1760821	usd
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1438560	usd
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13459408	usd
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15388239	usd
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12501621	usd
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2475032	usd
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1806299	usd
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1544521	usd
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	56151119	usd
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	56202808	usd
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	14430000	usd
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	14721000	usd
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	41606067	usd
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	14547000	usd
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	12778000	usd
CY2014Q4	us-gaap	Costs And Expenses CostsAndExpenses	13494000	usd
CY2013Q4	us-gaap	Costs And Expenses CostsAndExpenses	14314000	usd
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	13680000	usd
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	14390000	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	12899877	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	12302669	usd
CY2013	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	7535747	usd
CY2015	us-gaap	Interest Expense InterestExpense	-702095	usd
CY2014	us-gaap	Interest Expense InterestExpense	-884541	usd
CY2013	us-gaap	Interest Expense InterestExpense	-500362	usd
CY2015	us-gaap	Investment Income Net InvestmentIncomeNet	225270	usd
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	238928	usd
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	217598	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12817862	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11048457	usd
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7978471	usd
CY2015	us-gaap	Profit Loss ProfitLoss	15430383	usd
CY2014	us-gaap	Profit Loss ProfitLoss	13396769	usd
CY2015Q1	us-gaap	Profit Loss ProfitLoss	2519000	usd
CY2014Q1	us-gaap	Profit Loss ProfitLoss	2147000	usd
CY2013	us-gaap	Profit Loss ProfitLoss	10256362	usd
CY2014Q3	us-gaap	Profit Loss ProfitLoss	3256000	usd
CY2013Q3	us-gaap	Profit Loss ProfitLoss	3620000	usd
CY2014Q4	us-gaap	Profit Loss ProfitLoss	3455000	usd
CY2013Q4	us-gaap	Profit Loss ProfitLoss	3048000	usd
CY2015Q2	us-gaap	Profit Loss ProfitLoss	6200000	usd
CY2014Q2	us-gaap	Profit Loss ProfitLoss	4582000	usd
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2519732	usd
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3000639	usd
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1577820	usd
CY2015	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1037000	usd
CY2014	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1037000	usd
CY2013	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	598000	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-12770249	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-10333082	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-2584669	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	15383349	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	13974110	usd
CY2013	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	4897196	usd
CY2015	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Companys patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2015, 2014 and 2013 are summarized in the following table.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,398,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,360,536</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,187,690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">541,602</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,978,243</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,597,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,589,076</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,277,128</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,982,311</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,153,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481,865</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,770,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,333,082</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,584,669</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,383,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,897,196</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2015	FONR	Export Product Sales ExportProductSales	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; padding-left: 5.4pt">United Arab Emirates</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">-%</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">29.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">-%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Switzerland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Libya</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.2</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.1</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.8</td><td style="text-align: left">%</td></tr> </table>
CY2015	FONR	Export Service Revenues ExportServiceRevenues	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2013</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-left: 5.4pt">Spain</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">0.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Puerto Rico</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Switzerland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Germany</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">England</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Holland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Greece</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; padding-left: 5.4pt">Australia</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.2</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.1</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1.0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2015Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2014Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2015Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2014Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2015Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2014Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2013Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	-357500	usd
CY2015Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1284628	usd
CY2014Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1359093	usd
CY2013Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-866719	usd
CY2015Q2	us-gaap	Goodwill Goodwill	1767098	usd
CY2014Q2	us-gaap	Goodwill Goodwill	1767098	usd
CY2015Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	510492	usd
CY2014Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	583990	usd
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	135592	usd
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	95623	usd
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	120976	usd
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13272917	usd
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13390923	usd
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7539144	usd
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19501	usd
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-80499	usd
CY2015	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2339	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	3955	usd
CY2013	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	1885	usd
CY2015	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	11000	usd
CY2014	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	68943	usd
CY2013	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-567914	usd
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-699555	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-270482	usd
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	628033	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1262929	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1246672	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1169983	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1002736	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3470382	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2490146	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2890816	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5699302	usd
CY2014Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	8481830	usd
CY2015Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1093401	usd
CY2014Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	130822	usd
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2612521	usd
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2348312	usd
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2277891	usd
CY2015	FONR	Foreign Product Sales ForeignProductSales	74.2	pure
CY2014	FONR	Foreign Product Sales ForeignProductSales	42.4	pure
CY2013	FONR	Foreign Product Sales ForeignProductSales	3.8	pure
CY2015	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	7.4	pure
CY2014	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	8.8	pure
CY2013	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	8.2	pure
CY2015	us-gaap	Advertising Expense AdvertisingExpense	894000	usd
CY2014	us-gaap	Advertising Expense AdvertisingExpense	889000	usd
CY2013	us-gaap	Advertising Expense AdvertisingExpense	835000	usd
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	9293	usd
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1885	usd
CY2013	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	5838	usd
CY2015Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2015	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2015Q2	us-gaap	Cash Cash	7038000	usd
CY2014	us-gaap	Other Income OtherIncome	-608599	usd
CY2013	us-gaap	Other Income OtherIncome	725488	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	273028	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	2490146	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	2440108	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	2372514	usd
CY2014	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2013	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.16	pure
CY2015	FONR	Shares Issued Under Stock Bonus Plan SharesIssuedUnderStockBonusPlan	5000	shares
CY2014	FONR	Shares Issued Under Stock Bonus Plan SharesIssuedUnderStockBonusPlan	46708	shares
CY2013	FONR	Shares Issued Under Stock Bonus Plan SharesIssuedUnderStockBonusPlan	67870	shares
CY2002Q3	FONR	Fonar2002 Plan Permitted Issuances Of Stock Options Fonar2002PlanPermittedIssuancesOfStockOptions	100000	shares
CY2015	FONR	Fonar2002 Plan Options Outstanding Fonar2002PlanOptionsOutstanding	0	shares
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	35	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	34	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.9	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.6	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-65.4	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-65.5	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-76.2	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-27.4	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-29.2	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-35.6	pure
CY2015	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3544470	usd
CY2014	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3817205	usd
CY2013	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2421177	usd
CY2015	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y328D
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4266000	usd
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4571000	usd
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4035000	usd
CY2015	us-gaap	Litigation Settlement Amount LitigationSettlementAmount		usd
CY2014	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	13586	usd
CY2013	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	716250	usd
CY2015	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2538000	usd
CY2015	FONR	Recorded Sales Tax Obligations Interest And Penalties RecordedSalesTaxObligationsInterestAndPenalties	2509000	usd
CY2015	dei	Entity Registrant Name EntityRegistrantName	Fonar Corporation
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	8423306	usd
CY2015Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	510492	usd
CY2015Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	49170420	usd
CY2014Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	54900136	usd
CY2015Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122926000	usd
CY2015Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1133000	usd
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6730000	usd
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6392000	usd
CY2015	us-gaap	Other Expenses OtherExpenses	13	usd
CY2014	us-gaap	Other Expenses OtherExpenses	-4835	usd
CY2013	us-gaap	Other Expenses OtherExpenses	-141958	usd
CY2015	us-gaap	Other Income OtherIncome	394810	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	580708	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	8189448	usd
CY2015Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	3507204	usd
CY2014Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	3426982	usd
CY2015Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	3790981	usd
CY2014Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	4450125	usd
CY2015Q2	FONR	Medical Receivable MedicalReceivable	9082319	usd
CY2014Q2	FONR	Medical Receivable MedicalReceivable	8807856	usd
CY2015Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	14057962	usd
CY2014Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	11970388	usd
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30600	usd
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2015Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	1861350	usd
CY2014Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	1884984	usd
CY2015Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	539443	usd
CY2014Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	617592	usd
CY2015Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	-2693000	usd
CY2014Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	-3013000	usd
CY2015Q2	FONR	Estimated Earnings EstimatedEarnings	1371093	usd
CY2014Q2	FONR	Estimated Earnings EstimatedEarnings	1745608	usd
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6610	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-7412	shares
CY2015Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	9200000	usd
CY2015Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1937813	usd
CY2014Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1926813	usd
CY2015Q2	FONR	Diagnostic Imaging Facilities Managed By Imperial Management Llc DiagnosticImagingFacilitiesManagedByImperialManagementLlc	11	mricenter
CY2010Q3	FONR	Shares Registered Under Form S8 SharesRegisteredUnderFormS8	2000000	shares
CY2015	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	1151541	usd
CY2013Q1	FONR	Controlling Interest Acquired By Company Of Health Diagnostics Management Llc Hdm ControllingInterestAcquiredByCompanyOfHealthDiagnosticsManagementLlcHdm	0.505	pure
CY2013Q1	FONR	Health Diagnostics Management Hdm Class Outside Investors Members Contribution HealthDiagnosticsManagementHdmClassOutsideInvestorsMembersContribution	19800000	usd
CY2013Q1	FONR	Health Diagnostics Management Hdm Class B Company Members Contribution HealthDiagnosticsManagementHdmClassBCompanyMembersContribution	20200000	usd
CY2013Q1	FONR	Company Total Capital Contribution CompanyTotalCapitalContribution	14000000	usd
CY2013Q1	FONR	Interest Rate Of Revolving Credit Loan InterestRateOfRevolvingCreditLoan	0.04	pure
CY2013Q1	FONR	Bank Revolving Credit Loan BankRevolvingCreditLoan	3000000	usd
CY2015Q2	FONR	Hmca Ownership Percentage Of Imperial HmcaOwnershipPercentageOfImperial	0.96	pure
CY2011Q2	FONR	Private Placement Of Equity PrivatePlacementOfEquity	6000000	usd
CY2015Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2014Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2013Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1424900	usd
CY2015Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4510000	usd
CY2015Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	1109000	usd
CY2015	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2014	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2013	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2015	FONR	Average Monthly Payment For Stipulation Agreements AverageMonthlyPaymentForStipulationAgreements	19552	usd
CY2015Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	510000	usd
CY2014Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	298000	usd
CY2015	FONR	Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims	100000	usd
CY2013Q1	us-gaap	Bank Loans BankLoans	11000000	usd
CY2013Q1	us-gaap	Federal Home Loan Bank Advances Interest Rate FederalHomeLoanBankAdvancesInterestRate	0.0475	pure
	FONR	Number Of Consecutive Installments NumberOfConsecutiveInstallments	60	installments
CY2015Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	60.4	pure
CY2015	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2014	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2013	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.09	pure
CY2010Q2	FONR	Shares Reserved For2010 Stock Bonus Plan SharesReservedFor2010StockBonusPlan	2000000	shares
CY2014Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.5	pure
CY2010Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.152	pure
CY2011Q1	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.348	pure
CY2015Q1	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.2	pure
CY2013Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	.5	pure
CY2014Q2	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	700000	usd
CY2011Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	400000	usd
CY2015Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	4971094	usd
CY2013Q2	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	700000	usd
	FONR	Controlling Interest Description ControllingInterestDescription	The Company also has a 50% controlling interest in an entity which the Company consolidates, that provides management services to a diagnostic center in the New York Metropolitan area.
CY2015Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	8423306	usd
CY2014Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	5740287	usd
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8950160	usd
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10508843	usd
CY2015Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	236920	usd
CY2014Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	234581	usd
CY2015Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-31495	usd
CY2014Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-38828	usd
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	50783513	usd
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	45906592	usd
CY2015	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2014	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2013	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2015	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7939524	usd
CY2014	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7670484	usd
CY2013	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2704758	usd
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	394810	usd
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-608599	usd
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	725488	usd
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9448798	usd
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9951736	usd
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7870727	usd
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12032015	usd
CY2015Q2	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	38392742	usd
CY2014Q2	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	25311608	usd
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	30600	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2756517	usd
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2682405	usd
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2473892	usd
CY2015	FONR	Provision For Bad Debts ProvisionForBadDebts	2475032	usd
CY2014	FONR	Provision For Bad Debts ProvisionForBadDebts	1806299	usd
CY2013	FONR	Provision For Bad Debts ProvisionForBadDebts	1544521	usd
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-394797	usd
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	32944	usd
CY2015	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	7333	usd
CY2014	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	15992	usd
CY2013	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	15993	usd
CY2015Q2	FONR	Management Agreements With Company Non Related Medical Practices ManagementAgreementsWithCompanyNonRelatedMedicalPractices	17
CY2015Q2	FONR	Management Agreements With Company Related Medical Practices ManagementAgreementsWithCompanyRelatedMedicalPractices	3
CY2015Q2	FONR	Management Agreements With Company Total Medical Practices ManagementAgreementsWithCompanyTotalMedicalPractices	20
CY2015	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.54	pure
CY2014	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.5	pure
CY2013	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.41	pure
CY2015	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2014	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2013	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.16	pure
CY2014	FONR	Fonar2002 Plan Options Expired Fonar2002PlanOptionsExpired	6610	shares
CY2015Q2	FONR	Net Aggregates To Noncontrolling Interest In Entity Which Provides Management Services To Diagnostic Center In Ny Metro. NetAggregatesToNoncontrollingInterestInEntityWhichProvidesManagementServicesToDiagnosticCenterInNyMetro.	359157	usd
CY2014Q2	FONR	Net Aggregates To Noncontrolling Interest In Entity Which Provides Management Services To Diagnostic Center In Ny Metro. NetAggregatesToNoncontrollingInterestInEntityWhichProvidesManagementServicesToDiagnosticCenterInNyMetro.	531474	usd
CY2013Q2	FONR	Net Aggregates To Noncontrolling Interest In Entity Which Provides Management Services To Diagnostic Center In Ny Metro. NetAggregatesToNoncontrollingInterestInEntityWhichProvidesManagementServicesToDiagnosticCenterInNyMetro.	559221	usd
CY2015Q2	FONR	Common Stock Available Under Stock Bonus Plan CommonStockAvailableUnderStockBonusPlan	953367	shares
CY2015Q2	FONR	Fonar2005 Plan Shares Of Common Stock Available Fonar2005PlanSharesOfCommonStockAvailable	0	shares
CY2013	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	690000	usd
	FONR	Property Tax Abatement From Suffolk County Ida PropertyTaxAbatementFromSuffolkCountyIda	.5	pure
	FONR	Property Tax Abatement PropertyTaxAbatement	440000	usd
CY2013	FONR	Gain Recorded To Income Statement As Result Of Lawsuit GainRecordedToIncomeStatementAsResultOfLawsuit	755500	usd
CY2015	FONR	Included In Companys Accrued Expenses As Result Of Lawsuit IncludedInCompanysAccruedExpensesAsResultOfLawsuit	300000	usd
CY2014	FONR	Included In Companys Accrued Expenses As Result Of Lawsuit IncludedInCompanysAccruedExpensesAsResultOfLawsuit	300000	usd
CY2015	us-gaap	Interest Paid InterestPaid	516385	usd
CY2014	us-gaap	Interest Paid InterestPaid	668475	usd
CY2013	us-gaap	Interest Paid InterestPaid	389907	usd
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	143996	usd
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	349501	usd
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	277000	usd
CY2015	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.742	pure
CY2014	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	0.424	pure
CY2013	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	0.038	pure
CY2015	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	.074	pure
CY2014	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	.088	pure
CY2013	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	.082	pure
CY2015Q2	FONR	Ownership Interest Of Imperial In Hdm OwnershipInterestOfImperialInHdm	.242	pure
CY2015Q2	FONR	Ownership Interest Of Hmca In Hdm OwnershipInterestOfHmcaInHdm	.458	pure
CY2015Q2	FONR	Ownership Interest Of Original Investors In Hdm OwnershipInterestOfOriginalInvestorsInHdm	.3	pure
CY2015	FONR	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	-1125000	usd
CY2014	FONR	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	-1125100	usd
CY2013	FONR	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	-1424900	usd
CY2015	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	-1125000	usd
CY2014	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	-1125100	usd
CY2013	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	-1424900	usd
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	109950	usd
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	531825	usd
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2014	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	19800000	usd
CY2015	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment		usd
CY2014	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment		usd
CY2013	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	700000	usd
CY2015	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt		usd
CY2014	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt		usd
CY2013	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	14689646	usd
CY2015	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2014	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2013	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-40000000	usd
CY2015	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	109950	usd
CY2014	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	531825	usd
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2015	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2014	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2013	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	357500	usd
CY2015	FONR	Gain On Litigation Settlement GainOnLitigationSettlement		usd
CY2014	FONR	Gain On Litigation Settlement GainOnLitigationSettlement		usd
CY2013	FONR	Gain On Litigation Settlement GainOnLitigationSettlement	-755500	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	797458	usd
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-403393	usd
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-402361	usd
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-137438	usd
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2353124	usd
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2280044	usd
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2336454	usd
CY2015	FONR	True Ups TrueUps	-3.2	pure
CY2014	FONR	True Ups TrueUps	-2.8	pure
CY2013	FONR	True Ups TrueUps		pure
CY2015Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2508840	usd
CY2014Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2374339	usd
CY2015Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	510150	usd
CY2014Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	298004	usd
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1866277	usd
CY2015	FONR	Loss On Management Agreement LossOnManagementAgreement		usd
CY2014	FONR	Loss On Management Agreement LossOnManagementAgreement		usd
CY2013	FONR	Loss On Management Agreement LossOnManagementAgreement	-357500	usd
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-48777	usd
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-557473	usd
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	657350	usd
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-4627851	usd
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-4965770	usd
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-1799950	usd
CY2015	FONR	Proceeds From Noncontrolling Interests ProceedsFromNoncontrollingInterests		usd
CY2014	FONR	Proceeds From Noncontrolling Interests ProceedsFromNoncontrollingInterests		usd
CY2013	FONR	Proceeds From Noncontrolling Interests ProceedsFromNoncontrollingInterests	19800000	usd
CY2015	FONR	Buyout Of Noncontrolling Interests BuyoutOfNoncontrollingInterests	-4971094	usd
CY2014	FONR	Buyout Of Noncontrolling Interests BuyoutOfNoncontrollingInterests		usd
CY2013	FONR	Buyout Of Noncontrolling Interests BuyoutOfNoncontrollingInterests	-564315	usd
CY2015	FONR	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest	-4971094	usd
CY2014	FONR	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest		usd
CY2013	FONR	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest	-564315	usd
CY2015	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts		usd
CY2014	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts		usd
CY2013	FONR	Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts	142217	usd
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-190561	usd
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-268261	usd
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	253559	usd
CY2015Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	142217	usd
CY2014Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	142217	usd
CY2015	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1041214	usd
CY2014	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	295219	usd
CY2013	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-414402	usd
CY2015	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	24
CY2014	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	24
CY2013	FONR	Total Facilities Owned Or Managed At Beginning Of Year TotalFacilitiesOwnedOrManagedAtBeginningOfYear	11
CY2015	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	0
CY2015	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	0
CY2014	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	1
CY2013	FONR	Managed Facilities Closed During Year ManagedFacilitiesClosedDuringYear	1
CY2015Q2	FONR	Purchase Scanners PurchaseScanners		usd
CY2014	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	0
CY2013	FONR	Managed Facilities Added Acquisition ManagedFacilitiesAddedAcquisition	14
CY2014Q2	FONR	Purchase Scanners PurchaseScanners	450000	usd
CY2015	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	0
CY2014	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	1
CY2013	FONR	Managed Facilities Added By Internal Development ManagedFacilitiesAddedByInternalDevelopment	0
CY2015	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	24
CY2014	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	24
CY2013	FONR	Total Facilities Owned Or Managed At End Of Year TotalFacilitiesOwnedOrManagedAtEndOfYear	24
CY2015	FONR	Gain On Sale Of Equipment GainOnSaleOfEquipment		usd
CY2014	FONR	Gain On Sale Of Equipment GainOnSaleOfEquipment	40000	usd
CY2013	FONR	Gain On Sale Of Equipment GainOnSaleOfEquipment	557473	usd
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-657350	usd
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2015Q2	us-gaap	Other Liabilities OtherLiabilities	469198	usd
CY2014Q2	us-gaap	Other Liabilities OtherLiabilities	659759	usd
CY2015	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2014	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares
CY2013	FONR	Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders	127504	shares

Files In Submission

Name	View Source	Status
0000355019-15-000031-index-headers.html	Edgar Link	pending
0000355019-15-000031-index.html	Edgar Link	pending
0000355019-15-000031.txt	Edgar Link	pending
0000355019-15-000031-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonar2015_10k.htm	Edgar Link	pending
fonar_exhibit-21.htm	Edgar Link	pending
fonar_exhibit-23.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonr-20140630.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
fonr-20140630_cal.xml	Edgar Link	unprocessable
fonr-20140630_def.xml	Edgar Link	unprocessable
fonr-20140630_lab.xml	Edgar Link	unprocessable
fonr-20140630_pre.xml	Edgar Link	unprocessable
fonr-20140630.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2015 Q2 Form 10-K Financial Statement

#000035501915000031 Filed on September 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2015 Q2 Form 10-K Financial Statement

#000035501915000031 Filed on September 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr